Zunyan Dai

4.0k citations
45 papers · 3.0k indexed · h-index 27
Topics
Epigenetics and DNA Methylation (19 papers)RNA modifications and cancer (12 papers)Drug Transport and Resistance Mechanisms (7 papers)

In The Last Decade

Zunyan Dai

43 papers receiving 3.0k citations

Peers

Zunyan Dai
Comparison fields: 5 of 121
  • Molecular Biology 2.2k
  • Cancer Research 900
  • Oncology 665
  • Pulmonary and Respiratory Medicine 290
  • Genetics 255
Replace Raphael A. Nemenoff with:
Raphael A. Nemenoff United States
Luquan Wang United States
Yun‐Yong Park South Korea
Ángeles Durán United States
Masahiko Nishiyama Japan
Zhuchu Chen China
Claudia Friesen Germany
Fariba Behbod United States
Atul Bedi United States
Sergio Marchini Italy
Zunyan Dai relative to Raphael A. Nemenoff United States Raphael A. Nemenoff's profile →
Citations per field
00.5×1.5×
Raphael A. Nemenoff · 1×
Citations per year

Countries citing papers authored by Zunyan Dai

Since Specialization
Citations

This map shows the geographic impact of Zunyan Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zunyan Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zunyan Dai more than expected).

Fields of papers citing papers by Zunyan Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zunyan Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zunyan Dai. The network helps show where Zunyan Dai may publish in the future.

Co-authorship network of co-authors of Zunyan Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Zunyan Dai. A scholar is included among the top collaborators of Zunyan Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zunyan Dai. Zunyan Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 26
4 43
5 294
6 83
7 194
8 30
9 13
10 19
11 190
12 59
13 231
14 49
15 20
16 127
17 217
18 16
19 3
20 73

About Zunyan Dai

Zunyan Dai is a scholar working on Oncology, Molecular Biology and Biochemistry, having authored 45 papers that have together received 3.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (19 papers), RNA modifications and cancer (12 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Cancer Research (900 citations), Molecular Biology (2.2k citations) and Oncology (665 citations). Zunyan Dai has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Wolfgang Sadée, Ying Huang, Cátálin Bárbácioru, Christoph Plass, William C. Reinhold, John N. Weinstein, Paul E. Blower, Gregory A. Otterson, Wei‐Guo Zhu and Miguel A. Villalona‐Calero. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026